Cargando…

Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study

Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Francesco Paolo, Stefanizzi, Pasquale, Lattanzio, Sabrina, Diella, Giusy, Germinario, Cinzia Annatea, Tafuri, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067467/
https://www.ncbi.nlm.nih.gov/pubmed/35180368
http://dx.doi.org/10.1080/21645515.2022.2031698
_version_ 1784700010833641472
author Bianchi, Francesco Paolo
Stefanizzi, Pasquale
Lattanzio, Sabrina
Diella, Giusy
Germinario, Cinzia Annatea
Tafuri, Silvio
author_facet Bianchi, Francesco Paolo
Stefanizzi, Pasquale
Lattanzio, Sabrina
Diella, Giusy
Germinario, Cinzia Annatea
Tafuri, Silvio
author_sort Bianchi, Francesco Paolo
collection PubMed
description Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate the knowledge of new mothers toward the main vaccine-preventable diseases and to assess their compliance with recommended vaccinations. Using the Hospital Discharge Forms (SDO), the list of women who gave birth in 2018 was generated. Women were interviewed by a questionnaire administered by telephone. The study sample consisted of 145 subjects, with an average age of 35.0 ± 5.9 years (range = 18.0–47.0). 5/145 (3.4%; 95% CI = 1.1–7.9%) subjects were advised during pregnancy to have the flu shot; only 1/145 (0.7%; 95% CI = 0.5–71.6%) reported the flu vaccine during the last pregnancy. 94/145 (64.8%; 95% CI = 57.2–73.2%) respondents declared that they had carried out the TORCH panel exams before pregnancy; of these 18/94 (19.2%; 95% C = 11.8–28.6%) were susceptible for rubella. Of these subjects, for 7/18 (38.9%; 95% CI = 17.3–64.3%) rubella vaccination was offered and 5/7 (71.4%; 95% CI = 29.0–96.3%) decided to carry out the vaccination. Only 1/145 (0.7%; 95% CI = 0.0–3.8%) of the interviewed woman underwent anti-dTap vaccination. Greater efforts must be made by public health institutions to raise awareness and improve vaccination compliance in this population.
format Online
Article
Text
id pubmed-9067467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-90674672022-05-05 Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study Bianchi, Francesco Paolo Stefanizzi, Pasquale Lattanzio, Sabrina Diella, Giusy Germinario, Cinzia Annatea Tafuri, Silvio Hum Vaccin Immunother Research Paper Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate the knowledge of new mothers toward the main vaccine-preventable diseases and to assess their compliance with recommended vaccinations. Using the Hospital Discharge Forms (SDO), the list of women who gave birth in 2018 was generated. Women were interviewed by a questionnaire administered by telephone. The study sample consisted of 145 subjects, with an average age of 35.0 ± 5.9 years (range = 18.0–47.0). 5/145 (3.4%; 95% CI = 1.1–7.9%) subjects were advised during pregnancy to have the flu shot; only 1/145 (0.7%; 95% CI = 0.5–71.6%) reported the flu vaccine during the last pregnancy. 94/145 (64.8%; 95% CI = 57.2–73.2%) respondents declared that they had carried out the TORCH panel exams before pregnancy; of these 18/94 (19.2%; 95% C = 11.8–28.6%) were susceptible for rubella. Of these subjects, for 7/18 (38.9%; 95% CI = 17.3–64.3%) rubella vaccination was offered and 5/7 (71.4%; 95% CI = 29.0–96.3%) decided to carry out the vaccination. Only 1/145 (0.7%; 95% CI = 0.0–3.8%) of the interviewed woman underwent anti-dTap vaccination. Greater efforts must be made by public health institutions to raise awareness and improve vaccination compliance in this population. Taylor & Francis 2022-02-18 /pmc/articles/PMC9067467/ /pubmed/35180368 http://dx.doi.org/10.1080/21645515.2022.2031698 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Research Paper
Bianchi, Francesco Paolo
Stefanizzi, Pasquale
Lattanzio, Sabrina
Diella, Giusy
Germinario, Cinzia Annatea
Tafuri, Silvio
Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
title Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
title_full Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
title_fullStr Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
title_full_unstemmed Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
title_short Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
title_sort attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067467/
https://www.ncbi.nlm.nih.gov/pubmed/35180368
http://dx.doi.org/10.1080/21645515.2022.2031698
work_keys_str_mv AT bianchifrancescopaolo attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy
AT stefanizzipasquale attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy
AT lattanziosabrina attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy
AT diellagiusy attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy
AT germinariocinziaannatea attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy
AT tafurisilvio attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy